FrancophonIA/ELRC3.0 huggingface dataset:
English: Shake well prior to use to obtain a homogeneous white suspension.
Croatian: Dobro protresite prije uporabe kako biste dobili homogenu bijelu suspenziju.
English: Syringes should be stored in the refrigerator horizontally to minimize the re-dispersion time.
Croatian: Štrcaljke treba čuvati u hladnjaku vodoravno kako bi se skratilo vrijeme ponovne disperzije.
English: Fainting, feeling faint, or other stress-related reactions can occur as a response to any needle injection.
Croatian: Nesvjestica, osjećaj nesvjestice ili druge sa stresom povezane reakcije mogu se javiti kao odgovor na ubod iglom za injekciju.
English: Common (≥ 1/100 to < 1/10) Uncommon (≥ 1/1,000 to < 1/100) Rare (≥ 1/10,000 to < 1/1,000) Very rare (< 1/10,000)
Croatian: Manje često (≥1/1000 i <1/100) Rijetko (≥1/10 000 i <1/1000) Vrlo rijetko (<1/10 000)
English: The tip cap and rubber plunger of the pre-filled syringe are not made with natural rubber latex.
Croatian: Kapica na vrhu i gumeni klip napunjene štrcaljke nisu napravljeni od prirodne lateks gume.
English: Note: The lower limit of quantitation is an hSBA titre = 1:16 for PMB80 (A22) and 1:8 for PMB2001 (A56), PMB2948 (B24), and PMB2707 (B44).
Croatian: Napomena: Donja granica kvantifikacije je hSBA titar =1:16 za PMB80 (A22) i 1:8 za PMB2001 (A56), PMB2948 (B24) i PMB2707 (B44).
English: However, the presence of a minor infection, such as cold, should not result in the deferral of vaccination.
Croatian: Međutim, prisutnost manje infekcije poput prehlade, ne smije rezultirati odgodom cijepljenja.
English: Trumenba should not be given to individuals with thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection, unless the potential benefit clearly outweighs the risk of administration.
Croatian: Trumenba se ne smije dati osobama s trombocitopenijom ili bilo kojim poremećajem koagulacije zbog kojeg bi intramuskularna injekcija bila kontraindicirana, osim ako moguća korist jasno nadmašuje rizik od primjene.
English: The preferred site for injection is the deltoid muscle of the upper arm.
Croatian: Preferirano mjesto za injekciju je deltoidni mišić nadlaktice.
English: Common (these may affect up to 1 in 10 people) - Vomiting - Fever ≥ 38 °C
Croatian: Često (mogu se javiti u manje od 1 na 10 osoba): - povraćanje - vrućica ≥ 38°C
English: * The following is considered an adverse reaction for Trumenba and was reported in the postmarketing experience.
Croatian: *Navedeno se smatra nuspojavom Trumenbe i prijavljeno je nakon stavljanja lijeka u promet.
English: GMT (95% CI)
Croatian: N GMT (95% CI)
English: Before use, the pre-filled syringe should be shaken vigorously to ensure that a homogeneous white suspension is obtained.
Croatian: Prije uporabe, napunjenu štrcaljku treba snažno protresti kako bi se dobila homogena bijela suspenzija.
English: When Trumenba is given to your or your child, the following side effects may occur:
Croatian: Kada se Trumenba daje Vama ili Vašem djetetu, mogu se javiti sljedeće nuspojave:
English: Adverse reactions reported in clinical studies are listed in decreasing order of frequency and seriousness according to the following frequency categories:
Croatian: Nuspojave prijavljene u kliničkim ispitivanjima navedene su u padajućem nizu prema učestalosti i ozbiljnosti prema sljedećim kategorijama učestalosti:
English: Nervous system disorders Very Common: Headache
Croatian: Poremećaji živčanog sustava Vrlo često: Glavobolja
English: What Trumenba looks like and contents of the pack
Croatian: Kako Trumenba izgleda i sadržaj pakiranja
English: Reproduction studies performed in female rabbits have revealed no evidence of impaired female fertility or harm to the foetus due to Trumenba.
Croatian: Ispitivanja reprodukcije provedena na ženkama kunića nisu otkrila dokaz smanjene plodnosti u žena ili oštećenja fetusa zbog cjepiva Trumenba.
English: Study B1971033 is an open-label, follow-up study of subjects previously enrolled in a primary study, including Study B1971012.
Croatian: Ispitivanje B1971033 je otvoreno ispitivanje praćenja ispitanika prethodno uključenih u primarno ispitivanje, uključujući ispitivanje B1971012.
English: If this occurs, wait until the effects wear off before driving or using machines.
Croatian: Ako se to dogodi, prije vožnje ili rada sa strojevima pričekajte da učinak oslabi.
English: For the second and third doses, serum was obtained approximately 1 month after the second or third vaccination dose.
Croatian: Za drugu i treću dozu serum je prikupljen približno mjesec dana nakon cijepljenja drugom ili trećom dozom.
English: Administration of Trumenba with vaccines other than those mentioned above, has not been studied.
Croatian: Primjena Trumenbe s drugim cjepivima izuzev gore navedenih nije ispitivana.
English: Like all vaccines, this vaccine can cause side effects, although not everybody gets them.
Croatian: Kao i svi lijekovi, ovaj lijek može uzrokovati nuspojave iako se one neće javiti kod svakoga.
English: 1 dose (0.5 ml)
Croatian: 1 doza (0,5 ml)
English: Persons with familial complement deficiencies (for example, C5 or C3 deficiencies) and persons receiving treatments that inhibit terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis serogroup B, even if they develop antibodies following vaccination with Trumenba.
Croatian: Osobe s nasljednim nedostacima komplementa (na primjer, C5 ili C3 nedostaci) i osobe koje primaju liječenja koja inhibiraju aktiviranje terminalnog komplementa (na primjer, ekulizumab) imaju povećan rizik za invazivne bolesti uzrokovane s Neisseria meningitidis serotipa B, čak i ako razviju protutijela nakon cijepljenja Trumenbom.
English: For instructions on the handling of the vaccine before administration, see section 6.6.
Croatian: Za upute o rukovanju cjepivom prije primjene vidjeti dio 6.6.
English: It is important to follow the instructions from the doctor, pharmacist or nurse so that you or your child completes the course of injections.
Croatian: Važno je da slijedite upute liječnika ili medicinske sestre tako da Vi ili Vaše dijete primite sve injekcije iz ciklusa.
English: A survey of over 2,150 different invasive meningococcal serogroup B isolates collected from 2000-2014 in 7 European countries, the US and Canada demonstrated that over 91% of all meningococcal serogroup B isolates expressed sufficient levels of fHbp to be susceptible to bactericidal killing by vaccine-induced antibodies.
Croatian: Pregledom više od 2150 različitih izolata invazivnog meningokoka serogrupe B prikupljenih od 2000. do 2014. godine u 7 europskih država, SAD-u i Kanadi pokazalo se da više od 91% svih izolata meningokoka serogrupe B ima izraženu dostatnu razinu fHBP koja ih čini osjetljivim na baktericidno uništenje pomoću protutijela induciranih cjepivom.
English: total of 2,471 subjects received Trumenba and 822 received saline.
Croatian: Ukupno je 2471 ispitanik primio Trumenbu i 822 je primilo fiziološku otopinu.
English: Read all of this leaflet carefully before you or your child receives this vaccine because it contains important information for you or your child
Croatian: Vi ili Vaše dijete primite ovo cjepivo jer sadrži Vama i Vašem djetetu važne podatke.
English: If this is the case, then vaccination will be postponed.
Croatian: U tom će se slučaju cijepljenje odgoditi.
English: Persistence of immunity and response to booster vaccination
Croatian: Trajnost imuniteta i odgovor na docjepljivanje
English: The study assessed the safety, tolerability, immunogenicity, and demonstration of manufacturability of 3 lots of Trumenba administered on a 0-, 2-, and 6-month schedule.
Croatian: Ispitivanje je procjenjivalo sigurnost, podnošljivost, imunogenost i prikaz mogućnosti proizvodnje 3 serije Trumenbe primijenjene u rasporedu 0, 2 i 6 mjeseci.
English: EU/1/17/1187/001 - pack of 1 with separate needle EU/1/17/1187/002 - pack of 1 without needle EU/1/17/1187/003 - pack of 5 with separate needles EU/1/17/1187/004 - pack of 5 without needles EU/1/17/1187/005 - pack of 10 with separate needles EU/1/17/1187/006 - pack of 10 without needles
Croatian: EU/1/17/1187/001 - pakiranje od 1, s odvojenom iglom EU/1/17/1187/002 - pakiranje od 1, bez igle EU/1/17/1187/003 - pakiranje od 5, s odvojenom iglom EU/1/17/1187/004 - pakiranje od 5, bez igle EU/1/17/1187/005 - pakiranje od 10, s odvojenom iglom EU/1/17/1187/006 - pakiranje od 10, bez igle
English: Tell your doctor, pharmacist or nurse if you or your child are using, have recently used or might use any other medicines or have recently received any other vaccine.
Croatian: Obavijestite svog liječnika, ljekarnika ili medicinsku sestru ako Vi ili Vaše dijete uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
English: What Trumenba is and what it is used for
Croatian: Što je Trumenba i za što se koristi
English: During storage, a white deposit and clear supernatant may be observed.
Croatian: Tijekom čuvanja mogu se uočiti bijeli talog i bistri supernatant.
English: 3 doses: 2 doses (0.5 ml each) administered at least 1 month apart, followed by a third dose at least 4 months after the second dose (see section 5.1).
Croatian: 3 doze: 2 doze (svaka 0,5 ml) primijenjene u razmaku od barem mjesec dana, nakon čega slijedi treća doza barem 4 mjeseca nakon druge doze (vidjeti dio 5.1).
English: Do not inject intravenously, intradermally, or subcutaneously.
Croatian: Ne injicirati intravenski, intradermalno ili supkutano.
English: You or your child will receive 2 injections of the vaccine given at least 1 month apart and a third injection at least 4 months after the second injection.
Croatian: Vi ili Vaše dijete primit ćete 2 injekcije cjepiva dane u razmaku od barem mjesec dana i treću injekciju barem 4 mjeseca nakon druge injekcije.
English: fHbp is found on the surface of meningococcal bacteria and is essential for bacteria to avoid host immune defenses.
Croatian: fHBP se nalazi na površini meningokoka i bakteriji je neophodan kako bi izbjegla imunološku obranu domaćina.
English: There are no data on the use of Trumenba in immunocompromised individuals.
Croatian: Nema podataka o primjeni Trumenbe u imunokompromitiranih osoba.
English: 1 single-dose (0.5 ml) pre-filled syringe with needle 1 single-dose (0.5 ml) pre-filled syringe without needle 5 single-dose (0.5 ml) pre-filled syringes with needles 5 single-dose (0.5 ml) pre-filled syringes without needles 10 single-dose (0.5 ml) pre-filled syringes with needles 10 single-dose (0.5 ml) pre-filled syringes without needles
Croatian: 1 jednodozna (0,5 ml) napunjena štrcaljka s iglom 1 jednodozna (0,5 ml) napunjena štrcaljka bez igle 5 jednodoznih (0,5 ml) napunjenih štrcaljki s iglama 5 jednodoznih (0,5 ml) napunjenih štrcaljki bez igala 10 jednodoznih (0,5 ml) napunjenih štrcaljki s iglama 10 jednodoznih (0,5 ml) napunjenih štrcaljki bez igala
English: These additional hSBAs support and extend the breadth of vaccine coverage demonstrated by the 4 representative primary strains (Tables 3 and 4).
Croatian: Ti dodatni hSBA omogućavaju širi spektar zaštite koju cjepivo pruža, prikazano kroz 4 reprezentativna primarna soja (Tablice 3 i 4).
English: In the immunogenicity analysis for Trumenba, a response was defined as an hSBA titre of at least 1:8 or 1:16 depending on the hSBA strain.
Croatian: U analizi imunogenosti za Trumenbu, odgovor je definiran kao hSBA titar najmanje 1:8 ili 1:16, ovisno o soju korištenom u analizi hSBA.
English: Do not mix Trumenba with other vaccines or medicinal products in the same syringe.
Croatian: Nemojte miješati Trumenbu s drugim cjepivima ili lijekovima u istoj štrcaljki.
English: A composite response was defined as a response for all 4 hSBA strains combined.
Croatian: Kompozitni odgovor je definiran kao odgovor na sva 4 hSBA soja zajedno.
English: There are no data available on the interchangeability of Trumenba with other meningococcal group B vaccines to complete the vaccination series.
Croatian: Nema dostupnih podataka o zamjenjivosti Trumenbe drugim cjepivima protiv meningokoka grupe B kako bi se završila cijela serija cijepljenja.
English: There are no data on the use of Trumenba in subjects above 65 years of age.
Croatian: Nema podataka o primjeni Trumenbe u osoba starijih od 65 godina.
English: As with any vaccine, vaccination with Trumenba may not protect all vaccine recipients.
Croatian: Kao i kod drugih cjepiva, cijepljenje Trumenbom možda neće zaštititi sve cijepljene osobe.
English: Subjects attended visits over 4 years for collection of blood samples and received a single booster dose of Trumenba approximately 4 years after receipt of a primary series of 2 or 3 doses of Trumenba.
Croatian: Ispitanici su dolazili u posjete radi prikupljanja krvnih uzoraka tijekom 4 godine i primili pojedinačnu dozu docjepljivanja Trumenbe približno 4 godine nakon primanja primarnih serija od 2 ili 3 doze Trumenbe.
English: A total of 2,693 subjects received at least 1 dose of Trumenba and 897 received at least 1 dose of HAV vaccine/saline.
Croatian: Ukupno je 2693 ispitanika primilo barem 1 dozu Trumenbe i 897 je primilo barem jednu dozu cjepiva HAV/fiziološke otopine.
English: Dose 3 1170
Croatian: 3 doze 1170
English: Group 1 received Trumenba at months 0, 2, and 6.
Croatian: 1. skupina je primala Trumenbu u rasporedu 0, 2 i 6 mjeseci.
English: Recombinant lipidated fHbp (factor H binding protein) Produced in Escherichia coli cells by recombinant DNA technology Adsorbed on aluminium phosphate (0.25 milligram aluminium per dose)
Croatian: Rekombinantni lipidirani protein fHbp (koji veže faktor H) Proizvedeno u stanicama Escherichia coli tehnologijom rekombinantne DNK Adsorbirano na aluminijev fosfat (0,25 miligrama aluminija po dozi)
English: What Trumenba contains
Croatian: Što Trumenba sadrži
English: 0.5 ml suspension in a pre-filled syringe (Type I glass) with plastic Luer Lok adapter, chlorobutyl rubber plunger stopper, and a synthetic isoprene bromobutyl rubber tip cap with a plastic rigid tip cap cover with or without needle.
Croatian: 0,5 ml suspenzije u napunjenoj štrcaljki (staklo tipa I) s plastičnim Luer Lok nastavkom, čepom klipa od klorobutilne gume te kapicom na vrhu od sintetske izoprenske bromobutilne gume s plastičnim krutim pokrovom kapice na vrhu, sa ili bez igle.
English: Primary series 2 doses (0.5 ml each) administered at a 6 month interval (see section 5.1).
Croatian: Primarno cijepljenje 2 doze (svaka od 0,5 ml) primijenjene u razmaku od 6 mjeseci (vidjeti dio 5.1).
English: A booster response in hSBA responses at 1 month following a dose of Trumenba approximately 4 years after a primary series of 2 doses (Group 3) or 3 doses (Groups 1 and 2) was observed.
Croatian: Odgovor na docjepljivanje uočen je u hSBA odgovorima mjesec dana od doze Trumenbe, približno 4 godine nakon primarne serije od 2 doze (3. skupina) ili 3 doze (1. i 2. skupina).
English: Protection against invasive meningococcal disease is mediated by serum bactericidal antibodies to bacterial surface antigens.
Croatian: Zaštita od invazivne meningokokne bolesti posredovana je serumskim baktericidnim protutijelima na bakterijske površinske antigene.
English: All subjects received 4 study injections, either 2 or 3 doses of Trumenba and 1 or 2 doses of saline.
Croatian: Svi su ispitanici primili 4 injekcije u ispitivanju: 2 ili 3 doze Trumenbe i 1 ili 2 doze fiziološke otopine.
English: The 4 test strains express fHbP variants representing the 2 subfamilies (A and B) and, when taken together, are representative of meningococcal serogroup B strains causing invasive disease.
Croatian: Četiri testna soja imaju izražene varijante fHBP koje predstavljaju 2 potporodice (A i B) i koje zajedno predstavljaju sojeve meningokoka serogrupe B koji uzrokuju invazivnu bolest.
English: The most common adverse reactions observed were injection site pain, redness and swelling at the vaccination site, headache, fatigue, chills, diarrhoea, muscle pain, joint pain, and nausea.
Croatian: Najčešće uočene nuspojave bile su bol na mjestu injekcije, crvenilo i oticanje na mjestu cijepljenja, glavobolja, umor, zimica, proljev, bol u mišićima, bol u zglobovima i mučnina.
English: Similar results were observed in Groups 2 and 3 as observed in Group 1.
Croatian: Rezultati uočeni u 2. i 3. skupini slični su onima uočenima u 1. skupini.
English: There are no data from the use of Trumenba in pregnant women.
Croatian: Nema podataka o primjeni Trumenbe u trudnica.
English: Sodium chloride, histidine, water for injections, aluminium phosphate and polysorbate 80 (E433).
Croatian: Natrijev klorid, histidin, voda za injekciju, aluminijev fosfat i polisorbat 80 (E433).
English: Trumenba has no or negligible influence on the ability to drive and use machines.
Croatian: Trumenba ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Trumenba in one or more subsets of the paediatric population for prevention of invasive meningococcal disease caused by N. meningitidis serogroup B (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja cjepiva Trumenba u jednoj ili više podskupina pedijatrijske populacije kod prevencije invazivne meningokokne bolesti uzrokovane bakterijom N. meningitidis serogrupe B (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: A 4-fold increase in hSBA titre for each of the 4 primary meningococcal serogroup B test strains was defined as follows: (1) For subjects with a baseline hSBA titre < 1:4, a 4-fold response was defined as an hSBA titre ≥ 1:16.
Croatian: Četverostruko povećanje hSBA titra za svaki od 4 primarnih testnih sojeva meningokoka serogrupe B definirani su na sljedeći način: (1) U ispitanika s početnim titrom hSBA < 1:4, četverostruki odgovor definiran je kao hSBA titar ≥ 1:16.
English: Trumenba is for intramuscular use only.
Croatian: Trumenba je samo za intramuskularnu primjenu.
English: In Studies B1971009 and B1971016, the proportion of subjects achieving a defined hSBA titre after 3 doses of Trumenba, administered on a 0-, 2-, and 6-month schedule, was evaluated against a panel of 10 additional strains, each expressing a different fHbp variant (Table 5).
Croatian: U ispitivanjima B1971009 i B1971016, udio ispitanika koji su postigli definirani hSBA titar nakon 3 doze Trumenbe primijenjene po rasporedu 0, 2 i 6 mjeseci procijenjen je naspram panela od 10 dodatnih sojeva, a svaki od njih izražava različitu varijantu fHBP (Tablica 5).
English: Trumenba can be given concomitantly with any of the following vaccines: Tetanus Toxoid, Reduced Diphtheria Toxoid, Acellular Pertussis, and Inactivated Poliovirus Vaccine (TdaP-IPV), Quadrivalent Human Papillomavirus vaccine (HPV4), Meningococcal Serogroups A, C, Y, W conjugate vaccine (MenACWY) and Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap).
Croatian: Trumenba se može primijeniti istodobno s bilo kojim od sljedećih cjepiva: cjepivo protiv tetanusa (toksoid), difterije (smanjenog sadržaja toksoida), pertusisa (nestanično) i poliomijelitisa (inaktivirano) (TdaP-IPV), cjepivo protiv humanog papilomavirusa (četverovalentno) (HPV4), cjepivo protiv meningokoka serogrupa A, C, W i Y, konjugirano (MenACWY) i cjepivo protiv tetanusa (toksoid), difterije (smanjenog sadržaja toksoida) i pertusisa (nestanično), adsorbirano (Tdap).
English: Sodium chloride, histidine, water for injections, and polysorbate 80 (E433).
Croatian: Natrijev klorid, histidin, voda za injekciju i polisorbat 80 (E433).
English: Musculoskeletal and connective tissue disorders Very Common: Muscle pain (myalgia); joint pain (arthralgia)
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva Vrlo često: Bol u mišićima (mialgija); bol u zglobovima (artralgija)
English: One dose (0.5 ml) contains:
Croatian: Jedna doza (0,5 ml) sadrži:
English: Trumenba can be given at the same time as any of the following vaccine components: tetanus, diphtheria, whooping cough (pertussis), poliovirus, papillomavirus, and meningococcal serogroups A, C, Y, W.
Croatian: Trumenba se smije dati istodobno s bilo kojim sastojkom sljedećih cjepiva: tetanus, difterija, hripavac (pertusis), poliovirus, papilomavirus i meningokok serogrupe A, C, Y i W.
English: Very common (these may affect more than 1 in 10 people) - Redness, swelling and pain at injection site - Headache - Diarrhoea - Nausea - Muscle pain - Joint pain - Chills - Fatigue
Croatian: Vrlo često (mogu se javiti u više od 1 na 10 osoba): - crvenilo, oticanje i bol na mjestu injekcije - glavobolja - proljev - mučnina - bol u mišićima - bol u zglobovima - zimica - umor
English: fHbp variants segregate into 2 immunologically distinct subfamilies, A and B, and over 96% of meningococcal serogroup B isolates in Europe express fHbp variants from either subfamily on the bacterial surface.
Croatian: Varijante fHBP su razvrstane u dvije imunološki zasebne potporodice, A i B, a više od 96% izolata meningokoka serogrupe B u Europi ima na površini bakterije izražene varijante fHBP iz bilo koje potporodice.
English: In Study B1971012, Trumenba was administered according to the following schedules: Group 1 (0, 1, and 6 months); Group 2 (0, 2, and 6 months); Group 3 (0 and 6 months); Group 4 (0 and 2 months); Group 5 (0 and 4 months).
Croatian: U ispitivanju B1971012, Trumenba se primjenjivala prema sljedećim rasporedima: 1. skupina (0, 1 i 6 mjeseci); 2. skupina (0, 2 i 6 mjeseci); 3. skupina (0 i 6 mjeseci); 4. skupina (0 i 2 mjeseca); 5. skupina (0 i 4 mjeseci).
English: Study B1971009 (10-18 years of age)
Croatian: Ispitivanje B1971009 (10 do 18 godina starosti)
English: If you receive more than 1 vaccination at the same time it is important that different injection sites are used.
Croatian: Ako se istodobno primjenjuje više od jednog cjepiva, potrebno ih je injicirati na zasebna mjesta.
English: Dose 2 308
Croatian: 2 doze 308
English: Do not administer intravascularly or subcutaneously.
Croatian: Nemojte primjenjivati intravaskularno ili supkutano.
English: Tel+34914909900
Croatian: Télf:+34914909900
English: Trumenba is indicated for active immunisation of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.
Croatian: Trumenba je indicirana za aktivnu imunizaciju osoba u dobi od 10 godina i starijih radi sprječavanja invazivne meningokokne bolesti uzrokovane bakterijom Neisseria meningitidis serogrupe B.
English: Trumenba is a white suspension for injection, provided in a pre-filled syringe.
Croatian: Trumenba je bijela suspenzija za injekciju koja se isporučuje u napunjenoj štrcaljki.
English: (2) For subjects with a baseline hSBA titre ≥ 1:4, a 4-fold response was defined as an hSBA titre ≥ 4 times the lower limit of quantitation or ≥ 4 times the baseline titre, whichever was higher.
Croatian: (2) U ispitanika s početnim titrom hSBA ≥ 1:4, četverostruki odgovor definiran je kao hSBA titar ≥ 4 x donja granice kvantifikacije ili ≥ 4 x početni titar, štogod je više.
English: ≥ 4-Fold rise in hSBA titre (%)
Croatian: ≥ četverostruki porast hSBA titra (%)
English: Meningococcal group B vaccine (recombinant, adsorbed)
Croatian: Cjepivo protiv meningokoka grupe B (rekombinantno, adsorbirano)
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Croatian: Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: 48 Months after last primary Dose
Croatian: 48 mjeseci nakon posljednje primarne doze
English: Immunisation with Trumenba, which contains one fHbp variant each from subfamily A and B, is intended to stimulate the production of bactericidal antibodies that recognize fHbP expressed by meningococci.
Croatian: Imunizacija Trumenbom koja sadrži po jednu varijantu fHBP od svake potporodice A i B namijenjena je poticanju razvoja baktericidnih protutijela koja prepoznaju na meningokoku izražen fHbp.